Cargando…
USE OF TRANYLCYPROMINE IN SEVERE RESISTANT DEPRESSION : A CASE REPORT
This case report describes the improvement obtained by using tranylcypromine in a patient of severe treatment resistant depression. The adverse effects faced and steps taken to overcome them have also been discussed.
Autores principales: | Maulik, Pallab K., Das, Sudipto, Saxena, Shekhar |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2962842/ https://www.ncbi.nlm.nih.gov/pubmed/21455381 |
Ejemplares similares
-
Roadmap to strengthen global mental health systems to tackle the impact of the COVID-19 pandemic
por: Maulik, Pallab K., et al.
Publicado: (2020) -
Effects of in vitro Amitriptyline, Fluoxetine,
Tranylcypromine and Venlafaxine on Saphenous Vein Grafts
por: Akinci, Melek, et al.
Publicado: (2019) -
Safety of concomitant tranylcypromine treatment during electroconvulsive therapy (ECT) series
por: Kavakbasi, E., et al.
Publicado: (2022) -
Serotonin Syndrome Masquerading as Status Epilepticus following Ingestion of Tranylcypromine and Clomipramine and L-Tryptophan: A Case Report
por: Ambarapu, Swetha, et al.
Publicado: (2022) -
Tranylcypromine specificity for monoamine oxidase is limited by promiscuous protein labelling and lysosomal trapping
por: Drechsel, Jonas, et al.
Publicado: (2020)